Feedback / Questions
BH-30643 - BlossomHill Therap
https://www.globenewswire.com/news-release/2025/10/24/3172996/0/en/BlossomHill-Therapeutics-Presents-Preliminary-Findings-from-Phase-1-2-SOLARA-Trial-of-BH-30643-in-EGFR-mutant-NSCLC-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targ.html
Oct 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next